John W. Villiger
Director/Board Member presso Auckland UniServices Ltd.
Profilo
John W.
Villiger was the founder of The Medicines Co. which was founded in 1996, where he held the title of Executive Vice President.
Currently, he is a Board Member at Auckland UniServices Ltd.
Dr. Villiger's former positions include Chairman at Proacta, Inc. from 2012 to 2015, Independent Non-Executive Director at Syntara Ltd.
from 2011 to 2013, and Principal at Hoffmann-La Roche, Inc. Dr. Villiger received a doctorate degree from the University of Otago.
Posizioni attive di John W. Villiger
| Società | Posizione | Inizio |
|---|---|---|
Auckland UniServices Ltd.
 Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Director/Board Member | - |
Precedenti posizioni note di John W. Villiger
| Società | Posizione | Fine |
|---|---|---|
| SYNTARA LIMITED | Director/Board Member | 19/09/2013 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| THE MEDICINES COMPANY | Founder | - |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Chairman | - |
Formazione di John W. Villiger
| University of Otago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYNTARA LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Auckland UniServices Ltd.
Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Finance |
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Borsa valori
- Insiders
- John W. Villiger
